nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—lung cancer	0.23	0.476	CbGaD
Sevoflurane—CYP2E1—lung cancer	0.164	0.338	CbGaD
Sevoflurane—ALB—lung cancer	0.0899	0.186	CbGaD
Sevoflurane—ALB—Gefitinib—lung cancer	0.0298	0.153	CbGbCtD
Sevoflurane—ALB—Erlotinib—lung cancer	0.0176	0.0903	CbGbCtD
Sevoflurane—CYP2B6—Irinotecan—lung cancer	0.0162	0.0832	CbGbCtD
Sevoflurane—ALB—Irinotecan—lung cancer	0.0159	0.0815	CbGbCtD
Sevoflurane—CYP2B6—Cisplatin—lung cancer	0.0132	0.0678	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—lung cancer	0.0132	0.0675	CbGbCtD
Sevoflurane—CYP3A4—Topotecan—lung cancer	0.0102	0.0523	CbGbCtD
Sevoflurane—CYP3A4—Gefitinib—lung cancer	0.00933	0.0479	CbGbCtD
Sevoflurane—CYP3A4—Teniposide—lung cancer	0.00904	0.0464	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—lung cancer	0.00886	0.0454	CbGbCtD
Sevoflurane—ALB—Methotrexate—lung cancer	0.00841	0.0431	CbGbCtD
Sevoflurane—CYP3A4—Vinorelbine—lung cancer	0.00718	0.0369	CbGbCtD
Sevoflurane—CYP3A4—Crizotinib—lung cancer	0.00572	0.0293	CbGbCtD
Sevoflurane—CYP3A4—Erlotinib—lung cancer	0.00551	0.0283	CbGbCtD
Sevoflurane—CYP3A4—Paclitaxel—lung cancer	0.00505	0.0259	CbGbCtD
Sevoflurane—CYP3A4—Irinotecan—lung cancer	0.00498	0.0256	CbGbCtD
Sevoflurane—CYP3A4—Vinblastine—lung cancer	0.00443	0.0227	CbGbCtD
Sevoflurane—CYP3A4—Etoposide—lung cancer	0.00399	0.0205	CbGbCtD
Sevoflurane—CYP3A4—Docetaxel—lung cancer	0.00365	0.0187	CbGbCtD
Sevoflurane—KCNK2—mammary gland—lung cancer	0.00286	0.0896	CbGeAlD
Sevoflurane—CYP3A4—Doxorubicin—lung cancer	0.00272	0.014	CbGbCtD
Sevoflurane—ATP2C1—mammary gland—lung cancer	0.00152	0.0477	CbGeAlD
Sevoflurane—GABRP—mammary gland—lung cancer	0.00149	0.0468	CbGeAlD
Sevoflurane—ND1—respiratory system—lung cancer	0.00128	0.04	CbGeAlD
Sevoflurane—GABRE—mammary gland—lung cancer	0.00114	0.0357	CbGeAlD
Sevoflurane—ALB—mammary gland—lung cancer	0.00104	0.0325	CbGeAlD
Sevoflurane—ATP5D—respiratory system—lung cancer	0.00103	0.0322	CbGeAlD
Sevoflurane—ATP2C1—respiratory system—lung cancer	0.00102	0.0318	CbGeAlD
Sevoflurane—GABRP—respiratory system—lung cancer	0.000995	0.0312	CbGeAlD
Sevoflurane—ATP5D—bronchus—lung cancer	0.000847	0.0265	CbGeAlD
Sevoflurane—ATP2C1—bronchus—lung cancer	0.000836	0.0262	CbGeAlD
Sevoflurane—GABRP—bronchus—lung cancer	0.000819	0.0256	CbGeAlD
Sevoflurane—GRIA1—lung—lung cancer	0.000788	0.0247	CbGeAlD
Sevoflurane—ATP5D—trachea—lung cancer	0.00076	0.0238	CbGeAlD
Sevoflurane—ATP2C1—trachea—lung cancer	0.00075	0.0235	CbGeAlD
Sevoflurane—ND1—bone marrow—lung cancer	0.000748	0.0234	CbGeAlD
Sevoflurane—GABRP—trachea—lung cancer	0.000736	0.023	CbGeAlD
Sevoflurane—ATP5D—cardiac atrium—lung cancer	0.000714	0.0224	CbGeAlD
Sevoflurane—ATP2C1—cardiac atrium—lung cancer	0.000705	0.0221	CbGeAlD
Sevoflurane—KCNK2—lymph node—lung cancer	0.000692	0.0217	CbGeAlD
Sevoflurane—ND1—lung—lung cancer	0.000678	0.0212	CbGeAlD
Sevoflurane—GABRB3—respiratory system—lung cancer	0.000644	0.0202	CbGeAlD
Sevoflurane—GABRE—bronchus—lung cancer	0.000625	0.0196	CbGeAlD
Sevoflurane—ATP5D—bone marrow—lung cancer	0.000603	0.0189	CbGeAlD
Sevoflurane—ATP2C1—bone marrow—lung cancer	0.000595	0.0186	CbGeAlD
Sevoflurane—GABRE—trachea—lung cancer	0.000561	0.0176	CbGeAlD
Sevoflurane—ATP5D—lung—lung cancer	0.000546	0.0171	CbGeAlD
Sevoflurane—ATP2C1—lung—lung cancer	0.000539	0.0169	CbGeAlD
Sevoflurane—GABRP—lung—lung cancer	0.000528	0.0165	CbGeAlD
Sevoflurane—GABRE—cardiac atrium—lung cancer	0.000527	0.0165	CbGeAlD
Sevoflurane—ND1—lymph node—lung cancer	0.000463	0.0145	CbGeAlD
Sevoflurane—CYP2A6—lung—lung cancer	0.00046	0.0144	CbGeAlD
Sevoflurane—GABRB2—lung—lung cancer	0.000445	0.0139	CbGeAlD
Sevoflurane—CYP2B6—respiratory system—lung cancer	0.000437	0.0137	CbGeAlD
Sevoflurane—CYP2E1—respiratory system—lung cancer	0.00041	0.0128	CbGeAlD
Sevoflurane—GABRE—lung—lung cancer	0.000403	0.0126	CbGeAlD
Sevoflurane—ATP5D—lymph node—lung cancer	0.000374	0.0117	CbGeAlD
Sevoflurane—ATP2C1—lymph node—lung cancer	0.000369	0.0115	CbGeAlD
Sevoflurane—CYP2B6—bronchus—lung cancer	0.000359	0.0113	CbGeAlD
Sevoflurane—GABRB3—lung—lung cancer	0.000342	0.0107	CbGeAlD
Sevoflurane—GABRA2—lymph node—lung cancer	0.000278	0.00871	CbGeAlD
Sevoflurane—GABRE—lymph node—lung cancer	0.000276	0.00864	CbGeAlD
Sevoflurane—ALB—lymph node—lung cancer	0.000252	0.00788	CbGeAlD
Sevoflurane—CYP2B6—lung—lung cancer	0.000232	0.00726	CbGeAlD
Sevoflurane—CYP2E1—lung—lung cancer	0.000218	0.00681	CbGeAlD
Sevoflurane—Chills—Docetaxel—lung cancer	0.000136	0.000782	CcSEcCtD
Sevoflurane—Cough—Paclitaxel—lung cancer	0.000136	0.000782	CcSEcCtD
Sevoflurane—Asthenia—Vinorelbine—lung cancer	0.000135	0.00078	CcSEcCtD
Sevoflurane—Arrhythmia—Docetaxel—lung cancer	0.000135	0.000779	CcSEcCtD
Sevoflurane—Dyspnoea—Gemcitabine—lung cancer	0.000135	0.000778	CcSEcCtD
Sevoflurane—Chest pain—Etoposide—lung cancer	0.000135	0.000778	CcSEcCtD
Sevoflurane—Nausea—Vinblastine—lung cancer	0.000135	0.000777	CcSEcCtD
Sevoflurane—Somnolence—Gemcitabine—lung cancer	0.000135	0.000776	CcSEcCtD
Sevoflurane—Convulsion—Paclitaxel—lung cancer	0.000135	0.000776	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Irinotecan—lung cancer	0.000134	0.000774	CcSEcCtD
Sevoflurane—Hypertension—Paclitaxel—lung cancer	0.000134	0.000773	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000134	0.000772	CcSEcCtD
Sevoflurane—Pancreatitis—Methotrexate—lung cancer	0.000134	0.00077	CcSEcCtD
Sevoflurane—Pruritus—Vinorelbine—lung cancer	0.000133	0.000769	CcSEcCtD
Sevoflurane—Pain—Irinotecan—lung cancer	0.000133	0.000766	CcSEcCtD
Sevoflurane—Mental disorder—Docetaxel—lung cancer	0.000133	0.000764	CcSEcCtD
Sevoflurane—Chest pain—Paclitaxel—lung cancer	0.000132	0.000762	CcSEcCtD
Sevoflurane—Hypotension—Cisplatin—lung cancer	0.000132	0.00076	CcSEcCtD
Sevoflurane—Malnutrition—Docetaxel—lung cancer	0.000132	0.000759	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000131	0.000757	CcSEcCtD
Sevoflurane—Nausea—Topotecan—lung cancer	0.000131	0.000755	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000131	0.000754	CcSEcCtD
Sevoflurane—Confusional state—Etoposide—lung cancer	0.00013	0.000752	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—lung cancer	0.00013	0.000748	CcSEcCtD
Sevoflurane—Pain—Gemcitabine—lung cancer	0.00013	0.000747	CcSEcCtD
Sevoflurane—Nausea—Erlotinib—lung cancer	0.00013	0.000747	CcSEcCtD
Sevoflurane—Dry mouth—Paclitaxel—lung cancer	0.000129	0.000746	CcSEcCtD
Sevoflurane—Anaphylactic shock—Etoposide—lung cancer	0.000129	0.000745	CcSEcCtD
Sevoflurane—Dysgeusia—Docetaxel—lung cancer	0.000129	0.000743	CcSEcCtD
Sevoflurane—Feeling abnormal—Irinotecan—lung cancer	0.000128	0.000739	CcSEcCtD
Sevoflurane—Confusional state—Paclitaxel—lung cancer	0.000128	0.000737	CcSEcCtD
Sevoflurane—Dysuria—Methotrexate—lung cancer	0.000127	0.000734	CcSEcCtD
Sevoflurane—Oedema—Paclitaxel—lung cancer	0.000127	0.000731	CcSEcCtD
Sevoflurane—Anaphylactic shock—Paclitaxel—lung cancer	0.000127	0.000731	CcSEcCtD
Sevoflurane—Thrombocytopenia—Etoposide—lung cancer	0.000127	0.00073	CcSEcCtD
Sevoflurane—Tachycardia—Etoposide—lung cancer	0.000126	0.000728	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—lung cancer	0.000126	0.000726	CcSEcCtD
Sevoflurane—Dyspnoea—Cisplatin—lung cancer	0.000126	0.000725	CcSEcCtD
Sevoflurane—Skin disorder—Etoposide—lung cancer	0.000126	0.000724	CcSEcCtD
Sevoflurane—Feeling abnormal—Gemcitabine—lung cancer	0.000125	0.000719	CcSEcCtD
Sevoflurane—Shock—Paclitaxel—lung cancer	0.000125	0.000719	CcSEcCtD
Sevoflurane—Dizziness—Vinorelbine—lung cancer	0.000125	0.000719	CcSEcCtD
Sevoflurane—Nervous system disorder—Paclitaxel—lung cancer	0.000124	0.000717	CcSEcCtD
Sevoflurane—Thrombocytopenia—Paclitaxel—lung cancer	0.000124	0.000716	CcSEcCtD
Sevoflurane—Tachycardia—Paclitaxel—lung cancer	0.000124	0.000713	CcSEcCtD
Sevoflurane—Skin disorder—Paclitaxel—lung cancer	0.000123	0.00071	CcSEcCtD
Sevoflurane—Body temperature increased—Irinotecan—lung cancer	0.000123	0.000708	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Cisplatin—lung cancer	0.000122	0.000703	CcSEcCtD
Sevoflurane—Hypotension—Etoposide—lung cancer	0.000121	0.000697	CcSEcCtD
Sevoflurane—Pain—Cisplatin—lung cancer	0.000121	0.000696	CcSEcCtD
Sevoflurane—Vomiting—Vinorelbine—lung cancer	0.00012	0.000691	CcSEcCtD
Sevoflurane—Body temperature increased—Gemcitabine—lung cancer	0.00012	0.00069	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—lung cancer	0.000119	0.000688	CcSEcCtD
Sevoflurane—Rash—Vinorelbine—lung cancer	0.000119	0.000685	CcSEcCtD
Sevoflurane—Dermatitis—Vinorelbine—lung cancer	0.000119	0.000685	CcSEcCtD
Sevoflurane—Hypotension—Paclitaxel—lung cancer	0.000119	0.000683	CcSEcCtD
Sevoflurane—Headache—Vinorelbine—lung cancer	0.000118	0.000681	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—lung cancer	0.000118	0.000681	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—lung cancer	0.000118	0.000681	CcSEcCtD
Sevoflurane—Feeling abnormal—Cisplatin—lung cancer	0.000116	0.000671	CcSEcCtD
Sevoflurane—Loss of consciousness—Docetaxel—lung cancer	0.000116	0.000667	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—lung cancer	0.000116	0.000667	CcSEcCtD
Sevoflurane—Dyspnoea—Etoposide—lung cancer	0.000115	0.000665	CcSEcCtD
Sevoflurane—Somnolence—Etoposide—lung cancer	0.000115	0.000663	CcSEcCtD
Sevoflurane—Cough—Docetaxel—lung cancer	0.000115	0.000662	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—lung cancer	0.000115	0.000662	CcSEcCtD
Sevoflurane—Insomnia—Paclitaxel—lung cancer	0.000115	0.000661	CcSEcCtD
Sevoflurane—Hypersensitivity—Irinotecan—lung cancer	0.000115	0.00066	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—lung cancer	0.000114	0.000658	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—lung cancer	0.000114	0.000655	CcSEcCtD
Sevoflurane—Dyspnoea—Paclitaxel—lung cancer	0.000113	0.000652	CcSEcCtD
Sevoflurane—Somnolence—Paclitaxel—lung cancer	0.000113	0.00065	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—lung cancer	0.000112	0.000646	CcSEcCtD
Sevoflurane—Nausea—Vinorelbine—lung cancer	0.000112	0.000645	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Etoposide—lung cancer	0.000112	0.000644	CcSEcCtD
Sevoflurane—Body temperature increased—Cisplatin—lung cancer	0.000112	0.000643	CcSEcCtD
Sevoflurane—Asthenia—Irinotecan—lung cancer	0.000112	0.000643	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000111	0.000642	CcSEcCtD
Sevoflurane—Pain—Etoposide—lung cancer	0.000111	0.000638	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—lung cancer	0.00011	0.000636	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—lung cancer	0.00011	0.000632	CcSEcCtD
Sevoflurane—Haemoglobin—Methotrexate—lung cancer	0.00011	0.000632	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00011	0.000631	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—lung cancer	0.000109	0.000629	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—lung cancer	0.000109	0.000629	CcSEcCtD
Sevoflurane—Asthenia—Gemcitabine—lung cancer	0.000109	0.000626	CcSEcCtD
Sevoflurane—Pain—Paclitaxel—lung cancer	0.000108	0.000625	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—lung cancer	0.000108	0.000625	CcSEcCtD
Sevoflurane—Pharyngitis—Methotrexate—lung cancer	0.000108	0.000624	CcSEcCtD
Sevoflurane—Urinary tract disorder—Methotrexate—lung cancer	0.000108	0.000621	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—lung cancer	0.000108	0.00062	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—lung cancer	0.000108	0.00062	CcSEcCtD
Sevoflurane—Pruritus—Gemcitabine—lung cancer	0.000107	0.000618	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—lung cancer	0.000107	0.000616	CcSEcCtD
Sevoflurane—Feeling abnormal—Etoposide—lung cancer	0.000107	0.000614	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—lung cancer	0.000106	0.000613	CcSEcCtD
Sevoflurane—Shock—Docetaxel—lung cancer	0.000106	0.00061	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—lung cancer	0.000105	0.000608	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—lung cancer	0.000105	0.000607	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—lung cancer	0.000105	0.000605	CcSEcCtD
Sevoflurane—Feeling abnormal—Paclitaxel—lung cancer	0.000105	0.000602	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—lung cancer	0.000104	0.000602	CcSEcCtD
Sevoflurane—Hypersensitivity—Cisplatin—lung cancer	0.000104	0.0006	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—lung cancer	0.000103	0.000596	CcSEcCtD
Sevoflurane—Dizziness—Irinotecan—lung cancer	0.000103	0.000593	CcSEcCtD
Sevoflurane—Urticaria—Etoposide—lung cancer	0.000103	0.000592	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—lung cancer	0.000103	0.000591	CcSEcCtD
Sevoflurane—Body temperature increased—Etoposide—lung cancer	0.000102	0.000589	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—lung cancer	0.000102	0.000589	CcSEcCtD
Sevoflurane—Asthenia—Cisplatin—lung cancer	0.000101	0.000584	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—lung cancer	0.000101	0.000583	CcSEcCtD
Sevoflurane—Urticaria—Paclitaxel—lung cancer	0.000101	0.000581	CcSEcCtD
Sevoflurane—Hypotension—Docetaxel—lung cancer	0.0001	0.000579	CcSEcCtD
Sevoflurane—Body temperature increased—Paclitaxel—lung cancer	0.0001	0.000578	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—lung cancer	9.95e-05	0.000573	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—lung cancer	9.9e-05	0.00057	CcSEcCtD
Sevoflurane—Vomiting—Irinotecan—lung cancer	9.89e-05	0.00057	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—lung cancer	9.85e-05	0.000568	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—lung cancer	9.83e-05	0.000566	CcSEcCtD
Sevoflurane—Rash—Irinotecan—lung cancer	9.81e-05	0.000565	CcSEcCtD
Sevoflurane—Dermatitis—Irinotecan—lung cancer	9.8e-05	0.000565	CcSEcCtD
Sevoflurane—Chills—Methotrexate—lung cancer	9.79e-05	0.000564	CcSEcCtD
Sevoflurane—Headache—Irinotecan—lung cancer	9.75e-05	0.000561	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—lung cancer	9.73e-05	0.00056	CcSEcCtD
Sevoflurane—Vomiting—Gemcitabine—lung cancer	9.63e-05	0.000555	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—lung cancer	9.62e-05	0.000554	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—lung cancer	9.59e-05	0.000552	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—lung cancer	9.56e-05	0.000551	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—lung cancer	9.56e-05	0.000551	CcSEcCtD
Sevoflurane—Rash—Gemcitabine—lung cancer	9.55e-05	0.00055	CcSEcCtD
Sevoflurane—Dermatitis—Gemcitabine—lung cancer	9.55e-05	0.00055	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—lung cancer	9.53e-05	0.000549	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—lung cancer	9.5e-05	0.000547	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—lung cancer	9.49e-05	0.000547	CcSEcCtD
Sevoflurane—Headache—Gemcitabine—lung cancer	9.49e-05	0.000547	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—lung cancer	9.45e-05	0.000544	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—lung cancer	9.45e-05	0.000544	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—lung cancer	9.38e-05	0.00054	CcSEcCtD
Sevoflurane—Hypersensitivity—Paclitaxel—lung cancer	9.35e-05	0.000539	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—lung cancer	9.33e-05	0.000537	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—lung cancer	9.3e-05	0.000536	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—lung cancer	9.28e-05	0.000535	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—lung cancer	9.28e-05	0.000535	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—lung cancer	9.26e-05	0.000533	CcSEcCtD
Sevoflurane—Nausea—Irinotecan—lung cancer	9.24e-05	0.000532	CcSEcCtD
Sevoflurane—Pain—Docetaxel—lung cancer	9.2e-05	0.00053	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—lung cancer	9.15e-05	0.000527	CcSEcCtD
Sevoflurane—Asthenia—Paclitaxel—lung cancer	9.1e-05	0.000524	CcSEcCtD
Sevoflurane—Nausea—Gemcitabine—lung cancer	9e-05	0.000519	CcSEcCtD
Sevoflurane—Vomiting—Cisplatin—lung cancer	8.98e-05	0.000517	CcSEcCtD
Sevoflurane—Pruritus—Paclitaxel—lung cancer	8.98e-05	0.000517	CcSEcCtD
Sevoflurane—Rash—Cisplatin—lung cancer	8.91e-05	0.000513	CcSEcCtD
Sevoflurane—Dermatitis—Cisplatin—lung cancer	8.9e-05	0.000513	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—lung cancer	8.86e-05	0.000511	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—lung cancer	8.77e-05	0.000505	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—lung cancer	8.57e-05	0.000494	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—lung cancer	8.56e-05	0.000493	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—lung cancer	8.53e-05	0.000492	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—lung cancer	8.51e-05	0.00049	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—lung cancer	8.5e-05	0.00049	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—lung cancer	8.48e-05	0.000488	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—lung cancer	8.44e-05	0.000486	CcSEcCtD
Sevoflurane—Dizziness—Paclitaxel—lung cancer	8.39e-05	0.000483	CcSEcCtD
Sevoflurane—Nausea—Cisplatin—lung cancer	8.39e-05	0.000483	CcSEcCtD
Sevoflurane—Cough—Methotrexate—lung cancer	8.29e-05	0.000477	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—lung cancer	8.28e-05	0.000477	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—lung cancer	8.23e-05	0.000474	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—lung cancer	8.23e-05	0.000474	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—lung cancer	8.22e-05	0.000474	CcSEcCtD
Sevoflurane—Rash—Etoposide—lung cancer	8.16e-05	0.00047	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—lung cancer	8.15e-05	0.00047	CcSEcCtD
Sevoflurane—Headache—Etoposide—lung cancer	8.11e-05	0.000467	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—lung cancer	8.09e-05	0.000466	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—lung cancer	8.07e-05	0.000465	CcSEcCtD
Sevoflurane—Vomiting—Paclitaxel—lung cancer	8.07e-05	0.000465	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—lung cancer	8.05e-05	0.000464	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.03e-05	0.000463	CcSEcCtD
Sevoflurane—Rash—Paclitaxel—lung cancer	8e-05	0.000461	CcSEcCtD
Sevoflurane—Dermatitis—Paclitaxel—lung cancer	7.99e-05	0.00046	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—lung cancer	7.99e-05	0.00046	CcSEcCtD
Sevoflurane—Headache—Paclitaxel—lung cancer	7.95e-05	0.000458	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—lung cancer	7.92e-05	0.000456	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—lung cancer	7.82e-05	0.00045	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—lung cancer	7.75e-05	0.000447	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—lung cancer	7.72e-05	0.000445	CcSEcCtD
Sevoflurane—Nausea—Etoposide—lung cancer	7.69e-05	0.000443	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—lung cancer	7.61e-05	0.000438	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—lung cancer	7.6e-05	0.000438	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—lung cancer	7.59e-05	0.000437	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—lung cancer	7.56e-05	0.000435	CcSEcCtD
Sevoflurane—Nausea—Paclitaxel—lung cancer	7.54e-05	0.000434	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—lung cancer	7.53e-05	0.000434	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—lung cancer	7.37e-05	0.000425	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—lung cancer	7.24e-05	0.000417	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—lung cancer	7.23e-05	0.000416	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—lung cancer	7.18e-05	0.000413	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—lung cancer	7.12e-05	0.00041	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—lung cancer	7.11e-05	0.00041	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—lung cancer	7.1e-05	0.000409	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—lung cancer	7.01e-05	0.000404	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—lung cancer	7e-05	0.000403	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.95e-05	0.000401	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—lung cancer	6.91e-05	0.000398	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—lung cancer	6.89e-05	0.000397	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—lung cancer	6.85e-05	0.000394	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—lung cancer	6.84e-05	0.000394	CcSEcCtD
Sevoflurane—Rash—Docetaxel—lung cancer	6.78e-05	0.000391	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—lung cancer	6.77e-05	0.00039	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—lung cancer	6.77e-05	0.00039	CcSEcCtD
Sevoflurane—Headache—Docetaxel—lung cancer	6.74e-05	0.000388	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—lung cancer	6.71e-05	0.000387	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—lung cancer	6.71e-05	0.000387	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—lung cancer	6.69e-05	0.000386	CcSEcCtD
Sevoflurane—Pain—Methotrexate—lung cancer	6.63e-05	0.000382	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—lung cancer	6.6e-05	0.00038	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—lung cancer	6.58e-05	0.000379	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—lung cancer	6.57e-05	0.000379	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—lung cancer	6.55e-05	0.000377	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—lung cancer	6.52e-05	0.000376	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—lung cancer	6.39e-05	0.000368	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—lung cancer	6.39e-05	0.000368	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—lung cancer	6.27e-05	0.000361	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—lung cancer	6.16e-05	0.000355	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—lung cancer	6.13e-05	0.000353	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—lung cancer	6.07e-05	0.00035	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—lung cancer	5.98e-05	0.000345	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—lung cancer	5.97e-05	0.000344	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—lung cancer	5.79e-05	0.000334	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—lung cancer	5.74e-05	0.000331	CcSEcCtD
Sevoflurane—Hypersensitivity—Methotrexate—lung cancer	5.71e-05	0.000329	CcSEcCtD
Sevoflurane—Asthenia—Methotrexate—lung cancer	5.56e-05	0.00032	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—lung cancer	5.53e-05	0.000319	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—lung cancer	5.48e-05	0.000316	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—lung cancer	5.33e-05	0.000307	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—lung cancer	5.31e-05	0.000306	CcSEcCtD
Sevoflurane—Dizziness—Methotrexate—lung cancer	5.13e-05	0.000295	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—lung cancer	4.94e-05	0.000285	CcSEcCtD
Sevoflurane—Vomiting—Methotrexate—lung cancer	4.93e-05	0.000284	CcSEcCtD
Sevoflurane—Rash—Methotrexate—lung cancer	4.89e-05	0.000282	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—lung cancer	4.88e-05	0.000281	CcSEcCtD
Sevoflurane—Headache—Methotrexate—lung cancer	4.86e-05	0.00028	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—lung cancer	4.82e-05	0.000277	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—lung cancer	4.75e-05	0.000274	CcSEcCtD
Sevoflurane—Nausea—Methotrexate—lung cancer	4.6e-05	0.000265	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—lung cancer	4.44e-05	0.000256	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—lung cancer	4.27e-05	0.000246	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—lung cancer	4.23e-05	0.000244	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—lung cancer	4.23e-05	0.000244	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—lung cancer	4.2e-05	0.000242	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—lung cancer	3.99e-05	0.00023	CcSEcCtD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	9.84e-06	8.5e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTA2—lung cancer	9.78e-06	8.44e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTA1—lung cancer	9.63e-06	8.32e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ADCY1—lung cancer	9.62e-06	8.31e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCG2—lung cancer	9.62e-06	8.31e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCC3—lung cancer	9.52e-06	8.22e-05	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	9.51e-06	8.22e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HPGDS—lung cancer	9.43e-06	8.15e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ENO2—lung cancer	9.43e-06	8.15e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTA1—lung cancer	9.43e-06	8.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—RRM1—lung cancer	9.43e-06	8.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTA3—lung cancer	9.43e-06	8.14e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPP2R1B—lung cancer	9.37e-06	8.1e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCC3—lung cancer	9.33e-06	8.05e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKR1C1—lung cancer	9.22e-06	7.96e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTT1—lung cancer	9.15e-06	7.9e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GCLC—lung cancer	9.04e-06	7.81e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKR1C1—lung cancer	9.03e-06	7.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—AVP—lung cancer	8.99e-06	7.76e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—UGT1A1—lung cancer	8.95e-06	7.73e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—B4GALT5—lung cancer	8.86e-06	7.65e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ATP5H—lung cancer	8.86e-06	7.65e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—POMC—lung cancer	8.83e-06	7.63e-05	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—lung cancer	8.81e-06	7.61e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—UGT1A1—lung cancer	8.77e-06	7.57e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	8.71e-06	7.52e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	8.64e-06	7.46e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GNG11—lung cancer	8.63e-06	7.45e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTA4—lung cancer	8.62e-06	7.44e-05	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	8.6e-06	7.43e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ENO1—lung cancer	8.57e-06	7.4e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GNG11—lung cancer	8.45e-06	7.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.43e-06	7.28e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	8.41e-06	7.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTA2—lung cancer	8.4e-06	7.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MMP1—lung cancer	8.3e-06	7.17e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALDOA—lung cancer	8.22e-06	7.1e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTA1—lung cancer	8.11e-06	7e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALDOA—lung cancer	8.05e-06	6.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCC3—lung cancer	8.01e-06	6.92e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NCOA3—lung cancer	7.98e-06	6.89e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	7.96e-06	6.87e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—APOA1—lung cancer	7.94e-06	6.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLBD1—lung cancer	7.9e-06	6.82e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NCOA3—lung cancer	7.81e-06	6.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKR1C1—lung cancer	7.76e-06	6.7e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCG2—lung cancer	7.76e-06	6.7e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ADCY1—lung cancer	7.76e-06	6.7e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP2E1—lung cancer	7.69e-06	6.64e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ENO2—lung cancer	7.61e-06	6.57e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HPGDS—lung cancer	7.61e-06	6.57e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NQO1—lung cancer	7.6e-06	6.57e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ADCY1—lung cancer	7.6e-06	6.56e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCG2—lung cancer	7.6e-06	6.56e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPP2R1B—lung cancer	7.56e-06	6.53e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—lung cancer	7.54e-06	6.51e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—lung cancer	7.54e-06	6.51e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—UGT1A1—lung cancer	7.54e-06	6.51e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HPGDS—lung cancer	7.46e-06	6.44e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ENO2—lung cancer	7.46e-06	6.44e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPP2R1B—lung cancer	7.41e-06	6.4e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTT1—lung cancer	7.38e-06	6.38e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GCLC—lung cancer	7.3e-06	6.3e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP2A6—lung cancer	7.3e-06	6.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNG11—lung cancer	7.27e-06	6.27e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CG—lung cancer	7.25e-06	6.26e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTT1—lung cancer	7.23e-06	6.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.23e-06	6.24e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HSD17B10—lung cancer	7.22e-06	6.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EGF—lung cancer	7.17e-06	6.19e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP2A6—lung cancer	7.15e-06	6.17e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GCLC—lung cancer	7.15e-06	6.17e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ALDOA—lung cancer	6.92e-06	5.97e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ENO1—lung cancer	6.92e-06	5.97e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	6.87e-06	5.94e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—STK11—lung cancer	6.85e-06	5.92e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ENO1—lung cancer	6.78e-06	5.85e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CREBBP—lung cancer	6.72e-06	5.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOA3—lung cancer	6.72e-06	5.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CKB—lung cancer	6.71e-06	5.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.6e-06	5.7e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	6.57e-06	5.67e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ADCY1—lung cancer	6.53e-06	5.64e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCG2—lung cancer	6.53e-06	5.64e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HPGDS—lung cancer	6.41e-06	5.53e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ENO2—lung cancer	6.41e-06	5.53e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CD—lung cancer	6.37e-06	5.5e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPP2R1B—lung cancer	6.37e-06	5.5e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—lung cancer	6.34e-06	5.48e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM2—lung cancer	6.31e-06	5.45e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CNDP2—lung cancer	6.31e-06	5.45e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.28e-06	5.43e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTT1—lung cancer	6.21e-06	5.37e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP2E1—lung cancer	6.21e-06	5.36e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CAT—lung cancer	6.17e-06	5.33e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—lung cancer	6.16e-06	5.32e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—lung cancer	6.16e-06	5.32e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GCLC—lung cancer	6.14e-06	5.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2A6—lung cancer	6.14e-06	5.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTMR3—lung cancer	6.14e-06	5.3e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NQO1—lung cancer	6.14e-06	5.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.12e-06	5.28e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NQO1—lung cancer	6.01e-06	5.19e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—lung cancer	6e-06	5.18e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PGAM1—lung cancer	5.98e-06	5.17e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMS—lung cancer	5.9e-06	5.09e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—lung cancer	5.83e-06	5.03e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ENO1—lung cancer	5.82e-06	5.03e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	5.82e-06	5.02e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.8e-06	5.01e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2A7—lung cancer	5.71e-06	4.93e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAF1—lung cancer	5.69e-06	4.91e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SDC4—lung cancer	5.59e-06	4.82e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CB—lung cancer	5.56e-06	4.8e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—STK11—lung cancer	5.53e-06	4.78e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1A1—lung cancer	5.53e-06	4.77e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ERCC2—lung cancer	5.48e-06	4.73e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—STK11—lung cancer	5.42e-06	4.68e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	5.37e-06	4.63e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2E1—lung cancer	5.22e-06	4.51e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NQO1—lung cancer	5.16e-06	4.46e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—lung cancer	5.12e-06	4.42e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—lung cancer	5.1e-06	4.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—RRM1—lung cancer	5.09e-06	4.39e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA3—lung cancer	5.09e-06	4.39e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.06e-06	4.37e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—lung cancer	5.01e-06	4.33e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.01e-06	4.33e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CAT—lung cancer	4.98e-06	4.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	4.93e-06	4.25e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CAT—lung cancer	4.88e-06	4.21e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—lung cancer	4.84e-06	4.18e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—B4GALT5—lung cancer	4.78e-06	4.13e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMS—lung cancer	4.76e-06	4.11e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—lung cancer	4.74e-06	4.1e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APOA1—lung cancer	4.74e-06	4.09e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—lung cancer	4.7e-06	4.06e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMS—lung cancer	4.66e-06	4.02e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—STK11—lung cancer	4.66e-06	4.02e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA4—lung cancer	4.65e-06	4.02e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—lung cancer	4.61e-06	3.98e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EP300—lung cancer	4.58e-06	3.95e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA2—lung cancer	4.54e-06	3.92e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1A1—lung cancer	4.46e-06	3.85e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SRC—lung cancer	4.45e-06	3.84e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ERCC2—lung cancer	4.42e-06	3.82e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA1—lung cancer	4.38e-06	3.78e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.37e-06	3.77e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1A1—lung cancer	4.37e-06	3.77e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—lung cancer	4.34e-06	3.74e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ERCC2—lung cancer	4.33e-06	3.74e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CG—lung cancer	4.33e-06	3.74e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCC3—lung cancer	4.33e-06	3.74e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—lung cancer	4.31e-06	3.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—lung cancer	4.28e-06	3.7e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CAT—lung cancer	4.19e-06	3.62e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKR1C1—lung cancer	4.19e-06	3.62e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.17e-06	3.6e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—POMC—lung cancer	4.12e-06	3.56e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK3—lung cancer	4.1e-06	3.54e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—lung cancer	4.08e-06	3.52e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UGT1A1—lung cancer	4.07e-06	3.51e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CREBBP—lung cancer	4.01e-06	3.46e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMS—lung cancer	4e-06	3.46e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—lung cancer	3.96e-06	3.42e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNG11—lung cancer	3.92e-06	3.39e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APOA1—lung cancer	3.82e-06	3.3e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CD—lung cancer	3.8e-06	3.29e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALB—lung cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1A1—lung cancer	3.75e-06	3.24e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APOA1—lung cancer	3.75e-06	3.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALDOA—lung cancer	3.73e-06	3.23e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ERCC2—lung cancer	3.72e-06	3.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—lung cancer	3.69e-06	3.18e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOA3—lung cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ADCY1—lung cancer	3.53e-06	3.05e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCG2—lung cancer	3.53e-06	3.05e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CG—lung cancer	3.49e-06	3.02e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HPGDS—lung cancer	3.46e-06	2.99e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ENO2—lung cancer	3.46e-06	2.99e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.44e-06	2.97e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CG—lung cancer	3.42e-06	2.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—lung cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTT1—lung cancer	3.35e-06	2.9e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—POMC—lung cancer	3.32e-06	2.87e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GCLC—lung cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2A6—lung cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CB—lung cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—lung cancer	3.29e-06	2.84e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—lung cancer	3.28e-06	2.83e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—POMC—lung cancer	3.26e-06	2.81e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CREBBP—lung cancer	3.24e-06	2.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APOA1—lung cancer	3.22e-06	2.78e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CREBBP—lung cancer	3.17e-06	2.74e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ENO1—lung cancer	3.14e-06	2.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—lung cancer	3.13e-06	2.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.08e-06	2.66e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CD—lung cancer	3.07e-06	2.65e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALB—lung cancer	3.03e-06	2.62e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CD—lung cancer	3.01e-06	2.6e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALB—lung cancer	2.97e-06	2.56e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CG—lung cancer	2.94e-06	2.54e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—lung cancer	2.87e-06	2.47e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2E1—lung cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—POMC—lung cancer	2.8e-06	2.42e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NQO1—lung cancer	2.79e-06	2.41e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—lung cancer	2.77e-06	2.39e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—EP300—lung cancer	2.73e-06	2.36e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CREBBP—lung cancer	2.73e-06	2.35e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CB—lung cancer	2.68e-06	2.31e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—lung cancer	2.65e-06	2.29e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CB—lung cancer	2.62e-06	2.26e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—lung cancer	2.6e-06	2.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CD—lung cancer	2.58e-06	2.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—STK11—lung cancer	2.51e-06	2.17e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—lung cancer	2.33e-06	2.01e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—lung cancer	2.31e-06	2e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—lung cancer	2.26e-06	1.96e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CAT—lung cancer	2.26e-06	1.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CB—lung cancer	2.25e-06	1.94e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—lung cancer	2.23e-06	1.93e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—EP300—lung cancer	2.2e-06	1.9e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—lung cancer	2.2e-06	1.9e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMS—lung cancer	2.16e-06	1.87e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—EP300—lung cancer	2.16e-06	1.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—lung cancer	2.14e-06	1.85e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1A1—lung cancer	2.03e-06	1.75e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—lung cancer	2.02e-06	1.75e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ERCC2—lung cancer	2.01e-06	1.73e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—lung cancer	1.95e-06	1.68e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—EP300—lung cancer	1.86e-06	1.6e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APOA1—lung cancer	1.74e-06	1.5e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—lung cancer	1.65e-06	1.43e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—lung cancer	1.63e-06	1.41e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—lung cancer	1.6e-06	1.38e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CG—lung cancer	1.59e-06	1.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—POMC—lung cancer	1.51e-06	1.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CREBBP—lung cancer	1.47e-06	1.27e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CD—lung cancer	1.39e-06	1.2e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALB—lung cancer	1.38e-06	1.19e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—lung cancer	1.37e-06	1.19e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—lung cancer	1.33e-06	1.15e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—lung cancer	1.31e-06	1.13e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CB—lung cancer	1.22e-06	1.05e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—lung cancer	1.2e-06	1.04e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—lung cancer	1.12e-06	9.69e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—lung cancer	1.05e-06	9.07e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—EP300—lung cancer	1e-06	8.65e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—lung cancer	7.41e-07	6.4e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—lung cancer	6.05e-07	5.23e-06	CbGpPWpGaD
